Data Bridge Market Research analyses that the Circulating Tumor DNA (Ctdna) Market was USD 1234.58 million in 2021, would rocket up to USD 4335.17 million by 2029, and is expected to undergo a CAGR of 17% during the forecast period of 2022-2029.
Industry Analysis
Nucleated cells lacking CD45 and expressing cytokeratin were classified as circulating tumor cells. The use of circulating tumor DNA...
English 
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek